Skip to main content
ConductScienceScienceDex

Josep Maria Domingo-domenech

NIH Rank #5722
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12300579Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$1.9M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#5,722
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Josep Maria Domingo-domenech. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Josep Maria Domingo-domenech as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA280999-01A1R01
    Mechanisms and therapeutic targeting of lethal prostate cancer master regulator transcription factors
    Mayo Clinic
    $532.6K
    award amount
  • 1R01CA285345-01R01
    Mechanism and therapeutic targeting of castration resistance in SPOP-mutated prostate cancer
    Mayo Clinic
    $507.4K
    award amount
  • 1R01CA286864-01R01
    Mechanism and therapeutic targeting of abnormal androgenesis in CHD1-deficient prostate cancer
    Mayo Clinic
    $452.2K
    award amount
  • 5R01CA261925-04R01
    Determine the Microphthalmia Transcription Factor (MITF)-regulated cell rewiring mechanisms in lethal prostate cancer
    Mayo Clinic
    $434.9K
    award amount

Award organization

Organizations that administered FY2024 awards listing Josep Maria Domingo-domenech as a PI.

FY2024 award administered by Mayo Clinic (AZ).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Mayo Clinic
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5722
  5. 2025
    $2M Cumulative Funding
  6. 2025
    R01 Grant Holder
  7. 2026
    $5M Cumulative Funding
  8. 2026
    Entered Top 25% Nationally
    Ranked #3401

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Josep Maria Domingo-domenech.

Veronica Rodriguez-bravo
Mayo Clinic
6
shared awards
Zhenkun Lou
Mayo Clinic
3
shared awards

Explore further

Find collaborators for Josep Maria Domingo-domenech

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →